Lion Point Capital LP 13D and 13G filings for Lumos Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-12 3:56 pm Purchase | 2020-12-31 | 13G | Lumos Pharma, Inc. LUMO | Lion Point Capital LP | 407,192 4.900% | 407,192 (New Position) | Filing |